Orbenin La

4.1 Target species Cattle and sheep. 4.2 Indications for use, specifying the target species Orbenin L.A. is indicated for intramammary use in the treatment of bovine mastitis caused by Gram-positive organisms. For the best results it should be used at the earliest signs of infection. The product is also indicated as an intramammary infusion in ewes at weaning for the treatment and prevention of mastitis. Orbenin is effective against Streptococcus agalactiae and other streptococcal species, penicillin-resistant and sensitive staphylococci and Actinomyces pyogenes. In staphylococcal and certain forms of streptococcal mastitis, an adequate duration of treatment is important in achieving both clinical and bacteriological cures. Orbenin L.A. with its slow release characteristics is designed to meet these requirements. 4.3 Contraindications None. 4.4 Special warnings for each target species None. 4.5 Special precautions for use i) Special precautions for use in animals Individual syringes must only be used once. ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross-reactions to cephalosporins and vice versa. Allergic reaction to these substances may occasionally be serious. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. Wash hands after use. 4.6 Adverse reactions (frequency and seriousness) None. 4.7 Use during pregnancy, lactation or lay Orbenin L.A. is indicated for use in the lactating cow and for use in ewes at weaning. 4.8 Interaction with other medicinal products and other forms of interaction None known.
Vat Rate: 20%